Industry
New perspectives for treating psychiatric disorders
Scientists have determined the structure of Glycine Transporter 1. The finding could open new avenues for developing therapeutics for psychiatric…
EMBL facilities support development of RNA vaccines
Biotechnology company BioNTech and Johannes Gutenberg University Mainz conduct collaborative research with EMBL scientists at the beamline P12 in…
Life sciences open their doors for engineers
The European Molecular Biology Laboratory has secured 6.8 million Euros funding from the European Commission to launch a unique training programme.…
EIPOD4: 2019 applications are open
EIPOD4 will prepare researchers for the increasing interdisciplinarity of scientific career…
Welcome: Jessica Vamathevan
Building bonds between academia and…
Miltenyi Biotec becomes new corporate partner
Joining forces to advance training in biomedical research and…
Discovering new enzymes just got easier
EMBL-EBI industry case study:…
Science in industry
EMBL postdocs discover industry-led research opportunities at the Corporate Summer…
Sanofi joins Open Targets
Pharmaceutical company Sanofi strengthens drug targets discovery collaboration Open…
Promega joins EMBL’s Corporate Partnership Programme
EMBL and Promega collaborate to train young…
Open call for detector and imaging tech projects
The ATTRACT initiative, of which EMBL is a partner, has launched an open call for seed…
Roche joins EMBL’s Corporate Partnership Programme
Roche and EMBL join…
Last 6 months:
- April 2021 (11)
- March 2021 (17)
- February 2021 (23)
- January 2021 (17)
- December 2020 (18)
- November 2020 (12)
By year:
By topics:
- Alumni (101)
- Events (162)
- Lab Matters (399)
- Picture of the week (102)
- Science (706)
EMBLetc.
Read the latest Issues of our magazine - EMBLetc.
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive